Diabetic people have six times more risk of mucormycosis compared to non-diabetics and the finding is highly significant (OR: 6.55, P value: 0.002).
← all excerpts
Predictors for mucormycosis in COVID era: A case-control study from Gujarat.
2
—
—
The sentences
Mucormycosis is a deadly fungal infection and has shown an increasing trend during the COVID-19 pandemic globally and more so in India.[ 7 ] The overall mortality rate is approximately 50%, although early identification and treatment can lead to better outcomes.